{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:06:04Z","timestamp":1782889564051,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12350-020-02271-5","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T15:02:36Z","timestamp":1594393356000},"page":"113-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera"],"prefix":"10.1016","volume":"29","author":[{"given":"Quentin","family":"Brana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Courtehoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Metrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Joao","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Angoulvant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-0813","authenticated-orcid":false,"given":"Matthieu","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02271-5_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2967\/jnmt.109.065581","article-title":"Advances in pharmacologic stress agents: Focus on regadenoson","volume":"38","author":"Johnson","year":"2010","journal-title":"J Nucl Med Technol."},{"key":"10.1007\/s12350-020-02271-5_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nuclcard.2008.02.009","article-title":"Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial","volume":"15","author":"Leaker","year":"2008","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12350-011-9461-1","article-title":"Seizures associated with regadenoson: A case series","volume":"19","author":"Page","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.semnuclmed.2008.12.003","article-title":"Current advances in vasodilator pharmacological stress perfusion imaging","volume":"39","author":"Druz","year":"2009","journal-title":"Semin Nucl Med."},{"key":"10.1007\/s12350-020-02271-5_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jcmg.2009.04.011","article-title":"Regadenoson induces comparable left ventricular perfusion defects as adenosine: A quantitative analysis from the ADVANCE MPI 2 trial","volume":"2","author":"Mahmarian","year":"2009","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12350-014-9981-6","article-title":"Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: A quantitative analysis from the ADVANCE MPI trials","volume":"22","author":"Mahmarian","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcmg.2008.02.003","article-title":"Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results","volume":"1","author":"Cerqueira","year":"2008","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jcmg.2012.04.009","article-title":"Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching","volume":"5","author":"Iqbal","year":"2012","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib10","first-page":"129","article-title":"Regadenoson use in patients with chronic obstructive pulmonary disease: The state of current knowledge","volume":"9","author":"Golzar","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"10.1007\/s12350-020-02271-5_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s12350-016-0427-1","article-title":"An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis","volume":"24","author":"Hussain","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12350-016-0448-9","article-title":"Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers","volume":"24","author":"Rai","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12350-017-1038-1","article-title":"Regadenoson use for stress myocardial perfusion imaging in advance chronic kidney disease and dialysis: Safe, effective, and efficient","volume":"25","author":"Gupta","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib14","first-page":"5","article-title":"MedAxiom Nuclear Survey","volume":"21","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib15","doi-asserted-by":"crossref","unstructured":"Lindner O, Burchert W, Buechel R, Sch\u00e4fer WM, Im Namen der Arbeitsgemeinschaft \u201eKardiovaskul\u00e4re Nuklearmedizin\u201c der Deutschen Gesellschaft f\u00fcr Nuklearmedizin under AG20 \u201eNuklearkardiologische Diagnostik\u201c der Deutschen Gesellschaft f\u00fcr Kardiologie. Myocardial Perfusion SPECT 2018 in Germany: Results of the 8th Survey. Nukl Nucl Med 2019;58(6):425-33.","DOI":"10.1055\/a-1023-3960"},{"key":"10.1007\/s12350-020-02271-5_bib16","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2967\/jnumed.108.054478","article-title":"The clinical value of myocardial blood flow measurement","volume":"50","author":"Camici","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02271-5_bib17","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.115.165498","article-title":"Absolute myocardial blood flow and flow reserve assessed by gated SPECT with cadmium-zinc-telluride detectors using 99mTc-tetrofosmin: head-to-head comparison with 13 N-ammonia PET","volume":"57","author":"Nkoulou","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02271-5_bib18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00259-018-3958-7","article-title":"First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: Head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study","volume":"45","author":"Agostini","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib19","article-title":"Comparison between N13NH3-PET and 99mTc-Tetrofosmin-CZT SPECT in the evaluation of absolute myocardial blood flow and flow reserve","author":"Giubbini","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib20","article-title":"Quantification of myocardial perfusion reserve by CZT-SPECT: A head to head comparison with 82Rubidium PET imaging","author":"Acampa","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib21","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1007\/s00259-011-1853-6","article-title":"Comparison of the myocardial blood flow response to regadenoson and dipyridamole: A quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET","volume":"38","author":"Goudarzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.amjcard.2012.05.038","article-title":"Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy","volume":"110","author":"Bravo","year":"2012","journal-title":"Am J Cardiol."},{"key":"10.1007\/s12350-020-02271-5_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcmg.2014.11.016","article-title":"Regadenoson versus dipyridamole hyperemia for cardiac PET imaging","volume":"8","author":"Johnson","year":"2015","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib24","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00259-015-3139-x","article-title":"EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT\/CT: 2015 revision","volume":"42","author":"Verberne","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-8703(88)90492-9","article-title":"Dipyridamole cardiac imaging","volume":"115","author":"Iskandrian","year":"1988","journal-title":"Am Heart J."},{"key":"10.1007\/s12350-020-02271-5_bib26","unstructured":"lexiscan.pdf. [cited 2019 28]. https:\/\/www.astellas.us\/docs\/lexiscan.pdf."},{"key":"10.1007\/s12350-020-02271-5_bib27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00259-007-0478-2","article-title":"Quantification of myocardial blood flow with 82Rb dynamic PET imaging","volume":"34","author":"Lortie","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/01.RES.65.3.632","article-title":"Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium","volume":"65","author":"Leppo","year":"1989","journal-title":"Circ Res."},{"key":"10.1007\/s12350-020-02271-5_bib29","first-page":"1701","article-title":"Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia","volume":"37","author":"Yoshida","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02271-5_bib30","unstructured":"GraphPad Software, La Jolla California USA, www.graphpad.com."},{"key":"10.1007\/s12350-020-02271-5_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005344-200301000-00017","article-title":"Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging","volume":"41","author":"Trochu","year":"2003","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.1007\/s12350-020-02271-5_bib32","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3111\/13696998.2013.795488","article-title":"Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)","volume":"16","author":"Hudgens","year":"2013","journal-title":"J Med Econ."},{"key":"10.1007\/s12350-020-02271-5_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.103.053306","article-title":"Comparative profile of vasodilation by CVT-3146, ael A2A receptor agonist, and adenosine in conscious dogs","volume":"307","author":"Zhao","year":"2003","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1007\/s12350-020-02271-5_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/VHRM.S1798","article-title":"Regadenoson in the detection of coronary artery disease","volume":"4","author":"Buhr","year":"2008","journal-title":"Vasc Health Risk Manag."},{"key":"10.1007\/s12350-020-02271-5_bib35","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10554-011-0003-3","article-title":"Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients","volume":"28","author":"Husain","year":"2012","journal-title":"Int J Cardiovasc Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/jcis.JCIS_71_17","article-title":"Comparative performances of dipyridamole and regadenoson to detect myocardial ischemia using cardiac cadmium-zinc-telluride single-photon emission computerized tomography","volume":"8","author":"Bouall\u00e7gue","year":"2018","journal-title":"J Clin Imaging Sci."},{"key":"10.1007\/s12350-020-02271-5_bib37","article-title":"Differential effect of regadenoson versus dipyridamole on heart rate in patients with left bundle branch block: How does it affect the results of pharmacological nuclear stress testing?","volume":"8","author":"Assaad","year":"2019","journal-title":"JRSM Cardiovasc Dis."},{"key":"10.1007\/s12350-020-02271-5_bib38","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2005.05.097","article-title":"Initial clinical experience with regadenoson, ael selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging","volume":"46","author":"Hendel","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1007\/s12350-020-02271-5_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12350-012-9636-4","article-title":"Regadenoson pharmacologic rubidium-82 PET: A comparison of quantitative perfusion and function to dipyridamole","volume":"20","author":"Cullom","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1532-429X-15-85","article-title":"Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole: A study of first pass quantitative perfusion cardiovascular magnetic resonance","volume":"24","author":"Vasu","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-020-02271-5_bib41","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10554-011-9949-4","article-title":"The effect of obesity on regadenoson-induced myocardial hyperemia: A quantitative magnetic resonance imaging study","volume":"28","author":"DiBella","year":"2012","journal-title":"Int J Cardiovasc Imaging."},{"key":"10.1007\/s12350-020-02271-5_bib42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.carrev.2015.05.011","article-title":"Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory","volume":"16","author":"Stolker","year":"2015","journal-title":"Cardiovasc Revascularization Med Mol Interv."},{"key":"10.1007\/s12350-020-02271-5_bib43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nuclcard.2007.02.016","article-title":"Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans","volume":"14","author":"Lieu","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib44","first-page":"905","article-title":"Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement","volume":"11","author":"van Nunen","year":"2015","journal-title":"EuroInterv J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol."},{"key":"10.1007\/s12350-020-02271-5_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12933-017-0652-1","article-title":"Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus","volume":"17","author":"Potier","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"10.1007\/s12350-020-02271-5_bib46","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"10.1007\/s12350-020-02271-5_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183402","article-title":"Single-scan rest\/stress imaging with 99mTc-Sestamibi and cadmium zinc telluride-based SPECT for hyperemic flow quantification: A feasibility study evaluated with cardiac magnetic resonance imaging","volume":"12","author":"Fang","year":"2017","journal-title":"PLoS ONE."},{"key":"10.1007\/s12350-020-02271-5_bib48","article-title":"Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: Correlation and accuracy","author":"Zavadovsky","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib49","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2967\/jnumed.114.145342","article-title":"Comparison and prognostic validation of multiple methods of quantification of myocardial blood flow with 82Rb PET","volume":"55","author":"Murthy","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02271-5_bib50","article-title":"Impact of attenuation correction for CZT-SPECT measurement of myocardial blood flow","author":"Bailly","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02271-5_bib51","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2967\/jnumed.117.191049","article-title":"Optimization of SPECT measurement of myocardial blood flow with corrections for attenuation, motion, and blood binding compared with PET","volume":"58","author":"Wells","year":"2017","journal-title":"J Nucl Med."},{"key":"10.1007\/s12350-020-02271-5_bib52","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/phar.1940","article-title":"Regadenoson versus dipyridamole: A comparison of the frequency of adverse events in patients undergoing myocardial perfusion imaging","volume":"37","author":"Amer","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1007\/s12350-020-02271-5_bib53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02271-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:08:30Z","timestamp":1761026910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123002167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1071358123002167"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02271-5","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02271-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}